U.S. tuberculosis aid would prioritize care, prevention, and research

The President could provide aid to prevent, treat, and eliminate tuberculosis. The policy focuses on countries receiving U.S. foreign aid, especially those with high TB rates. Care priorities include people with drug-resistant TB. When providing aid, the President would have to prioritize patient care, stronger health systems, and research. The amendment replacing the TB assistance section would stop having effect beginning January 1, 2033.

The President would set global TB goals and update the national plan for fighting drug-resistant TB. Targets include cutting the rate of new TB cases by 80% and the TB death rate by 90% from 2015 levels, and providing preventive treatment to 30 million people. The President would consult the relevant congressional committees. The targets would be goals to work toward, not guaranteed results. The global goals cover January 1, 2027, through December 31, 2030.

The President would send Congress yearly reports, and a federal official would separately evaluate TB aid programs. The evaluation would cover TB prevention, diagnosis, treatment, and care supported by U.S. aid programs for individual countries. Reports would cover aid results and progress and gaps in developing TB tools. Aid reports would be due December 15 each year until the goals are met or December 31, 2032, whichever comes first. Research reports would begin within one year after enactment and continue annually through December 31, 2032. The evaluation would be due within four years after enactment.